Copeptin Levels During Cardiac Surgery
2025 (English)In: Journal of Cardiothoracic and Vascular Anesthesia, ISSN 1053-0770, E-ISSN 1532-8422, Vol. 39, no 5, p. 1197-1204Article in journal (Refereed) Published
Abstract [en]
Objectives: To investigate copeptin levels during the full perioperative course in open, adult cardiac surgery with cardiopulmonary bypass (CPB). Design: Prospective cohort study. Setting: A single-center study conducted in a tertiary care hospital. Participants: We included 61 patients undergoing various cardiac surgical procedures. In the final analysis, 57 patients were evaluated. Patients were divided into 2 subgroups based on preoperative copeptin levels, either above or below the reference level of 10 pmol/L. Interventions: No intervention. Measurements and Main Results: Copeptin levels were measured at multiple time points preoperatively, perioperatively, and postoperatively. Copeptin levels significantly increased from a preoperative median of 6.6 pmol/L (interquartile range [IQR], 3.9-11.0) to 27 pmol/L (IQR, 15.0-66.0 pmol/L) after sternotomy (p < 0.001). Peak levels occurred 60 minutes after CPB initiation, reaching 286 pmol/L (IQR, 163-446 pmol/L). After this, the copeptin levels did not drop significantly until CPB termination at 179.5 pmol/L (IQR, 136.0-346.0 pmol/L) (p < 0.001). Subsequent decreases were observed upon arrival in the intensive care unit and throughout the postoperative period. However, at 4 days postoperatively, copeptin levels remained significantly higher (11.5 pmol/L; IQR,7.2-19.0 pmol/L; p <0.001), than preoperative levels. Conclusions: This study describes copeptin levels during the perioperative course in adult cardiac surgery. The elevated levels during CPB suggest a strong activation of the arginine vasopressin system, with peak levels exceeding those seen in septic shock. This knowledge will enable further targeted clinical studies on copeptin as a prognostic marker in the field of cardiac surgery. (c) 2025 The Authors. Published by Elsevier Inc.
Place, publisher, year, edition, pages
W B SAUNDERS CO-ELSEVIER INC , 2025. Vol. 39, no 5, p. 1197-1204
Keywords [en]
copeptin; vasopressin; arginine vasopressin; AVP; cardiac surgery; cardiopulmonary bypass; heart-lung machine; biomarkers
National Category
Surgery
Identifiers
URN: urn:nbn:se:liu:diva-213711DOI: 10.1053/j.jvca.2025.02.014ISI: 001482197600001PubMedID: 40023700Scopus ID: 2-s2.0-85219002245OAI: oai:DiVA.org:liu-213711DiVA, id: diva2:1959736
Note
Funding Agencies|Region Ostergotland; Region Ostergotland
2025-05-212025-05-212025-09-08